Search for Clinical Trial Results
Primary Myelofibrosis - 26 Studies Found
Status | Study |
Recruiting |
Study Name: Ruxolitinib Phosphate and Chemotherapy Given Before and After Reduced Intensity Donor Stem Cell Transplant in Treating Patients With Myelofibrosis Condition:
|
Completed |
Study Name: A Long-Term Study of the Effects of Orally Administered SAR302503 in Patients With Myelofibrosis Condition: Myelofibrosis Date: 2008-07-17 Interventions: Drug: SAR302503 (TG101348) orally administered, once a day |
Completed |
Study Name: Study of Ruxolitinib (INCB018424) Sustained Release Formulation in Myelofibrosis Patients Condition: Myelofibrosis Date: 2011-04-21 Interventions: Drug: Ruxolitinib Ruxolitinib was supplied as SR and IR formulated tablets. |
Recruiting |
Study Name: Interferon-pegyle α2a Efficiency and Tolerance in Myelofibrosis Condition: Myelofibrosis Date: 2016-08-26 |
Active, not recruiting |
Study Name: Lenalidomide for Patients With Myelofibrosis (MF) Condition: Myelofibrosis Date: 2006-07-14 Interventions:
|
Completed |
Study Name: A Clinical Study of Ruxolitinib in Patients With Primary Myelofibrosis (PM), Post-polycythemia Vera (PV) Myelofibrosis, or Post-essential Thrombocythemia (ET) Myelofibrosis Condition: Primary Myelofibrosis (MF) Date: 2014-03-12 Interventions: Drug: Ruxolitinib |
Active, not recruiting |
Study Name: JAK2 Inhibitors RUXOLITINIB in Patients With Myelofibrosis Condition: Myelofibrosis Date: 2012-12-21 Interventions: Drug: Ruxolotinib Ruxolotinib doses calculated with platelets count and P450 cytochrome inhibitor HSCT f |
Active, not recruiting |
Study Name: Panobinostat and Ruxolitinib In MyElofibrosis (PRIME Trial) Condition: Myelofibrosis Date: 2012-09-14 Interventions:
|
Recruiting |
Study Name: Prospective Assessment of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis Condition: Myelofibrosis Date: 2016-09-30 Interventions: Other: Hematopoietic Stem Cell Transplant This observational study will compare outcomes of prospectivel |
Recruiting |
Study Name: JAK Inhibitor Before Donor Stem Cell Transplant in Treating Patients With Primary or Secondary Myelofibrosis Condition:
|